SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)

Background: Children born SGA are predisposed to metabolic abnormalities. While the therapeutic benefit of rhGH therapy in improving height is widely recognised, it can affect carbohydrate metabolism, potentially inducing diabetes. This ongoing, prospective study aims to evaluate the long-term safet...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Schwarz, Hans-Peter, Giemza, Tomasz, Jathanakodi, Shrihari, Zouater, Hichem, Zabransky, Markus
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2019
Teme:
Pediatric Endocrinology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552986/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-254
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki